About Tija
Tija is a company based in Noida (India) founded in 2024. It operates as a D2C. Tija offers products and services including Tija Device and Blood Pressure Monitor. Tija operates in a competitive market with competitors including Blood, Samphire Neuroscience, Ovira, Silifarm and Livia, among others.
- Headquarter Noida, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website tija.co.in
- Social LinkedIn X Facebook Instagram
- Legal Name Eyep Techproducts Pvt, Ltd
- Date of Incorporation 15 Jan, 2016
- Jurisdiction New Delhi, Delhi, India
- Annual Revenue₹39.6 Lakh
FY 2025 · -50% YoY
- Net Profit₹64,502
FY 2025 · 2% margin
- EBITDA₹67,784
FY 2025 · 2% margin
Associated legal entities of Tija
Tija is associated with 2 registered companies on The Company Check; the primary company is Eyep Techproducts Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Eyep Techproducts Private Limited CIN U74999UP2016PTC236929 | Active | 15 Jan 2016 | Ghaziabad, Uttar Pradesh | ₹0.4 Cr | – | 2 | View details |
| Eyep Techproducts Pvt, Ltd CIN U74999DL2016PTC289636 | – | 15 Jan 2016 | New Delhi, Delhi, India | – | – | – | View details |
Products & Services of Tija
Tija offers a comprehensive portfolio of products and services, including Tija Device and Blood Pressure Monitor.
Provides drug-free relief from menstrual cramps using TENS technology.
Monitors blood pressure for health tracking purposes.
Board of directors of Eyep Techproducts Private Limited (Tija)
Eyep Techproducts Private Limited is the primary company behind Tija. The board of Eyep Techproducts Private Limited currently have 2 directors; the longest-serving is Navdeep Singh Bhatia, appointed in 2016. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Navdeep Singh Bhatia DIN 00957047 | Director | 15 Jan 2016 | 10 yrs 8 mo | Eyep Techproducts Private Limited |
| Esheet Kaur Bhatia DIN 08791747 | Additional Director | 14 Jul 2020 | 6 yrs 2 mo | Eyep Techproducts Private Limited |
Financials of Tija
Figures of Eyep Techproducts Private Limited, the primary company behind Tija, for FY 2025. Revenue was ₹39.6 Lakh (-50% year on year). Net profit was ₹64,502 (2% margin). EBITDA was ₹67,784 (2% margin). Revenue has grown at a compounded annual rate of -9% over three years and +71% over five years.
- ₹39.6 LakhRevenue · FY 2025 · -50% YoY
- ₹64,502Net profit · 2% margin
- ₹67,784EBITDA · 2% margin
- ₹1 LakhPaid-up capital
- -9%Revenue CAGR, 3 years
- +71%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Eyep Techproducts Private Limited are on its company page.
Detailed financial statements for Tija
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Tija
Tija operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Blood, Samphire Neuroscience, Ovira, Silifarm and Livia, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| getblood.com | 2003 | Singapore | $1.5M | – | Personal hygiene products are offered online by an internet-first brand. | |
| samphireneuro.com | 2021 | London, United Kingdom | $7.3M | 2 | Developer of neuroscientific tools for PMS and period pain relief. It offers a brain stimulation headband and a cycle-tracking app designed to alleviate symptoms associated with PMDD, PMS, PME, and endometriosis. The headband uses non-invasive, low-level stimulation to target brain areas regulating mood and emotional balance. The app helps predict difficult days and track symptom patterns. The company focuses on providing medically-regulated, clinically-certified technologies for safe and effective symptom management. It also invests in educational resources to increase public awareness of the connection between the brain and menstrual cycle. | |
| ovira.com | 2010 | Bentleigh, Australia | $1.5M | – | Developer of device for treating menstrual pain | |
| silifarm.com | 2020 | Howrah, India | $152,724 | – | A portable rechargeable device for menstrual pain relief is developed. | |
| mylivia.com | 2015 | Tiberias, Israel | – | – | Wearable devices are offered to alleviate menstrual pain in women. | |
| galmedics.com | 2008 | Jerusalem, Israel | – | – | Develops gynecological devices for treating dysmenorrhea. |
Detailed competitors of Tija
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Tija
10 companies that operate in the same segment as Tija (Pain Management), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Developer of therapeutics for pain relief and inflammatory diseases | 2004 | New York, New York, United States | USD 51 M | USD 4.33 M | 79 | |
GPCR ligand-based therapeutics for cardiovascular diseases and pain are developed. | 2007 | Philadelphia, Pennsylvania, United States | USD 203 M | USD 3.13 M | 35 | |
Therapeutics for migraine treatment are developed using nasal delivery. | 2016 | San Francisco, California, United States | USD 74.13 M | – | 24 | |
Pain treatment products are developed through reformulation technologies. | 2007 | Herzliya, Central District, Israel | USD 12 M | USD 17 K | 6 | |
Drug delivery systems for CNS disorders and pain are developed. | 2006 | Emeryville, California, United States | USD 149.06 M | – | – | |
Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment | 2010 | Bloomington, Indiana, United States | USD 530 M | USD 91.65 M | – | |
Therapies for pain and addiction treatment are developed. | 1977 | Saint-cloud, France | USD 248.09 M | USD 167.87 M | – | |
Novel drug products for chronic pain treatment are developed. | 2007 | Blue Bell, Pennsylvania, United States | USD 12.96 M | – | 17 | |
Abuse-deterrent extended-release therapeutics for chronic pain are developed. | 2002 | Canton, Ohio, United States | USD 103 M | USD 780.57 M | 357 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Tija
Tija was founded in 2024.
Tija is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
The primary company behind Tija, Eyep Techproducts Private Limited, reported revenue of ₹39.6 Lakh for FY 2025, down 50% year on year.
Tija is a wearable device that uses Transcutaneous Electrical Nerve Stimulation (TENS) to block pain signals for menstrual relief. It sends mild electrical pulses, providing a non-invasive, drug-free alternative developed with medical professionals. Certified for safety, it addresses abdomen and back pain effectively. Based in Noida, India, Tija serves women seeking convenient pain management solutions through online sales.
Tija's top competitors include Blood, Samphire Neuroscience and Silifarm.
Tija offers Tija Device and Blood Pressure Monitor.
Tija operates through Eyep Techproducts Private Limited.
The legal entities of Tija currently have 2 directors, including Navdeep Singh Bhatia, Esheet Kaur Bhatia.